<DOC>
	<DOCNO>NCT02706769</DOCNO>
	<brief_summary>National guideline advocate use paracetamol conjunction strong opioids cancer pain , despite lack evidence efficacy . Work need examine analgesic benefit paracetamol large patient group . The investigator aim establish paracetamol combination strong opioids provide superior analgesia cancer relate pain strong opioids alone .</brief_summary>
	<brief_title>Paracetamol Versus Placebo Conjunction With Strong Opioids Cancer Pain</brief_title>
	<detailed_description />
	<mesh_term>Acetaminophen</mesh_term>
	<criteria>1 . Age 16 year 2 . Under palliative care/oncology service review 3 . Diagnosis incurable cancer 4 . Clinicianpredicted life expectancy &gt; 2 month 5 . Anticipated clinically stable duration study involvement 6 . Receiving daily regular strong opioids 7 . Able take study drug/placebo current form 8 . Prescribed take paracetamol 1g four time day 9 . Average pain &gt; 3 &lt; 9 past 24 hour 10 . Able provide write informed consent 11 . Able complete necessary assessment require part trial 12 . Average NRS pain score stable ( ie . maximum range 1 point ) three consecutive day prior randomisation 1 . Pain clinician deems unstable 2 . Clinically significant renal liver disease 3 . Weight le 50kg 4 . Those whose pain expect change course study result oncological treatment 5 . Coenrolment drug trial 6 . Known pregnant breastfeeding time recruitment 7 . Previously enrol study</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>